Cargando…
Design of a randomized controlled trial of smoking cessation medications for alcohol reduction among HIV-positive heavy drinkers and daily smokers in St. Petersburg, Russia
BACKGROUND: HIV, heavy drinking, and smoking are all pro-inflammatory and increase risk for coronary heart disease (CHD). Interventions that reduce alcohol use, smoking, or both in HIV-positive people could lower inflammation, CHD and death risk. Varenicline and cytisine are proven therapies for smo...
Autores principales: | Tindle, Hilary A., Freiberg, Matthew S., Gnatienko, Natalia, Blokhina, Elena, Cheng, Debbie M., Yaroslavtseva, Tatiana, Bendiks, Sally, Winter, Michael, Krupitsky, Evgeny, Samet, Jeffrey H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889999/ https://www.ncbi.nlm.nih.gov/pubmed/33659761 http://dx.doi.org/10.1016/j.conctc.2020.100625 |
Ejemplares similares
-
Design of a randomized controlled trial to Link Infectious and Narcology Care (LINC-II) in St. Petersburg, Russia
por: Gnatienko, Natalia, et al.
Publicado: (2020) -
Depression and smoking characteristics among HIV-positive smokers in Russia: A cross-sectional study
por: Lasser, Karen E., et al.
Publicado: (2018) -
Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial
por: Tindle, Hilary A., et al.
Publicado: (2022) -
Mortality in HIV-Infected Alcohol and Drug Users in St. Petersburg, Russia
por: Fairbairn, Nadia S., et al.
Publicado: (2016) -
Per-protocol analysis of the ZINC trial for HIV disease among alcohol users
por: Lodi, Sara, et al.
Publicado: (2021)